Bicheng Liu
Overview
Explore the profile of Bicheng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
2270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan Y, Li X, Cao J, Cao J, Wang Y, Wang L, et al.
J Clin Hypertens (Greenwich)
. 2025 Jan;
27(1):e14969.
PMID: 39826131
To assess the effectiveness and safety of Sacubitril/Valsartan in reducing blood pressure in individuals with non-dialysis-dependent chronic kidney disease (NDD-CKD) Stage 3-5 complicated by hypertension. This study was a multicenter...
2.
Wang X, Zhang J, Xu Y, Huang Y, Ming W, Jiao Y, et al.
Comput Biol Med
. 2025 Jan;
186:109670.
PMID: 39799830
Accurate segmentation and classification of glomeruli are fundamental to histopathology slide analysis in renal pathology, which helps to characterize individual kidney disease. Accurate segmentation of glomeruli of different types faces...
3.
Cheng Y, Hu H, Li W, Nie S, Zhou S, Chen Y, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39657910
Introduction: Thyroid dysfunction is prevalent in chronic kidney disease (CKD) patients and significantly impacts renal outcomes and mortality. This study investigated the associations between thyroid function and clinical outcomes, and...
4.
Wang Y, Zhang Y, Gao M, Chen Z, Lu J, Li Y, et al.
Cell Death Dis
. 2024 Nov;
15(11):865.
PMID: 39613734
Vascular calcification (VC) is a common complication of chronic kidney disease (CKD), for which no effective therapies are available. Hyperphosphatemia, a feature of CKD, is a well-known inducer of VC....
5.
Cai L, Su L, Hu Y, Cai E, Xu H, Liu B, et al.
Ren Fail
. 2024 Nov;
46(2):2432541.
PMID: 39593231
Background: Inflammation is associated with adverse outcomes of chronic kidney disease (CKD) or chronic heart failure (CHF), but few large data exist. We aimed to explore the clinical associations, and...
6.
Wang F, Li X, Liu R, Wang Y, Liu L, Zhang X, et al.
Clin Case Rep
. 2024 Nov;
12(11):e9542.
PMID: 39540002
The entrapment of the left renal vein (LRV) may contribute to changes in hemodynamics within kidney and could also be associated with IgA nephropathy (IgAN). Although the relationship between the...
7.
Chen S, Tang R, Liu B
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337709
The burden of chronic kidney disease (CKD) is increasing, posing a serious threat to human health. Cardiovascular calcification (CVC) is one of the most common manifestations of CKD, which significantly...
8.
Li T, Lu R, Cao Y, Liu B, Fu A, Liu B
Materials (Basel)
. 2024 Aug;
17(16).
PMID: 39203188
Graphene/copper composites are promising in electronic and energy fields due to their superior conductivity, but microstructure control during thermal mechanical processing (TMP) remains a crucial issue for the manufacturing of...
9.
Ye Z, Fan L, Yan R, Liu B, Zhou L, Xing G, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2579-2580.
PMID: 39156167
[This corrects the article DOI: 10.1016/j.ekir.2024.02.771.].
10.
Wang Y, Di Y, Li Y, Lu J, Ji B, Zhang Y, et al.
Chin Med J (Engl)
. 2024 Aug;
138(1):68-78.
PMID: 39149978
Background: Renal osteodystrophy (ROD) is a skeletal pathology associated with chronic kidney disease-mineral and bone disorder (CKD-MBD) that is characterized by aberrant bone mineralization and remodeling. ROD increases the risk...